Back
TransMedics Group 10K Form
Buy
69
TMDX
TransMedics Group
Last Price:
$68.45
Seasonality Move:
23.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TMDX News And Ratings
See the #1 stock for the next 7 days that we like better than TMDX
TMDX Financial Statistics
Sales & Book Value
| Annual Sales: | $441.5M |
|---|---|
| Cash Flow: | $6.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.80 |
| Price / Book: | 10.09 |
Profitability
| EPS (TTM): | 1.01000 |
|---|---|
| Net Income (TTM): | $35.5M |
| Gross Margin: | $262.1M |
| Return on Equity: | 19.17% |
| Return on Assets: | 4.69% |
TransMedics Group Earnings Forecast
Key TransMedics Group Financial Ratios
-
The Gross Profit Margin over the past 9 years for TMDX is 59.36%.
-
The Selling, General & Administrative Expenses for TMDX have been equal to 38.19% of Gross Profit Margin.
-
The Research & Development expenses have been 12.68% of Revenue.
-
The Interest Expense is 40.63% of Operating Income.
-
The Net Earning history of TMDX is 8.03% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 6 years.
TransMedics Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | TMDX |
| CUSIP: | 89377M |
| Website: | transmedics.com |
Debt
| Debt-to-Equity Ratio: | 2.23 |
|---|---|
| Current Ratio: | 8.3 |
| Quick Ratio: | 7.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 64.03 |
|---|---|
| Forward P/E Ratio: | 30.65 |
TMDX Technical Analysis vs Fundamental Analysis
Buy
69
TransMedics Group (TMDX)
is a Buy
Is TransMedics Group a Buy or a Sell?
-
TransMedics Group stock is rated a BuyThe current TransMedics Group [TMDX] share price is $68.51. The Score for TMDX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.